Literature DB >> 31634780

High glucose inhibits myogenesis and induces insulin resistance by down-regulating AKT signaling.

Wei Luo1, Lei Ai2, Bo-Fa Wang3, Yue Zhou4.   

Abstract

BACKGROUND: A high glucose level is usually considered to be the factor that induces tissue and cell dysfunction and damage, commonly known as "glucose toxicity".
OBJECTIVE: This study aimed to explore the effects and the potential molecular mechanisms of high glucose on myoblast differentiation and insulin sensitivity.
MATERIALS AND METHODS: C2C12 cells were cultured in differentiation medium containing 25, 40, or 60 mM glucose for 1, 3, or 5 days. E-MHC positive area and GLUT4 fluorescence were evaluated through Immunofluorescence. The expression of Myf5, MyoD, myogenin were measured by performing western blot and qRT-PCR. The protein expression of GLUT4 on cell membrane and glucose uptake in C2C12 myotubes were measured through western blot and 2-NBDG assay. AKT activator SC79 and inhibitor MK2206 was utilized to reveal the important role of AKT signaling in myogenesis and insulin sensitivity inhibited by high glucose.
RESULTS: 60 mM glucose inhibits myogenesis by decreasing the expression of MyoD and myogenin, and induces insulin resistance by reducing both basal and insulin-stimulated GLUT4 expressions and glucose uptakes. The influences of high glucose on myogenesis and IR was related to decreased AKT activation. SC79 rescued the inhibition of high glucose on myogenesis and attenuated IR. MK2206 inhibits the myogenic differentiation and induces IR.
CONCLUSION: The present study reveals that high glucose inhibited myogenisis accompanied by inducing IR, through AKT signaling inhibition, which may help to further research for resisting degenerative muscular diseases caused by glucose metabolism disorders.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  AKT-GLUT4; High glucose; Insulin resistence; Myoblast; Myogenesis

Mesh:

Substances:

Year:  2019        PMID: 31634780     DOI: 10.1016/j.biopha.2019.109498

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  8 in total

1.  Molecular and biochemical regulation of skeletal muscle metabolism.

Authors:  Morgan D Zumbaugh; Sally E Johnson; Tim H Shi; David E Gerrard
Journal:  J Anim Sci       Date:  2022-08-01       Impact factor: 3.338

Review 2.  In vitro skeletal muscle models for type 2 diabetes.

Authors:  Christina Y Sheng; Young Hoon Son; Jeongin Jang; Sung-Jin Park
Journal:  Biophys Rev (Melville)       Date:  2022-09-13

Review 3.  Exocytosis Proteins: Typical and Atypical Mechanisms of Action in Skeletal Muscle.

Authors:  Jinhee Hwang; Debbie C Thurmond
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-14       Impact factor: 6.055

Review 4.  New insights into the role of melatonin in diabetic cardiomyopathy.

Authors:  Keming Huang; Xianling Luo; Yi Zhong; Li Deng; Jian Feng
Journal:  Pharmacol Res Perspect       Date:  2022-02

5.  All-trans retinoic acid changes muscle fiber type via increasing GADD34 dependent on MAPK signal.

Authors:  Yuichiro Adachi; Masashi Masuda; Iori Sakakibara; Takayuki Uchida; Yuki Niida; Yuki Mori; Yuki Kamei; Yosuke Okumura; Hirokazu Ohminami; Kohta Ohnishi; Hisami Yamanaka-Okumura; Takeshi Nikawa; Yutaka Taketani
Journal:  Life Sci Alliance       Date:  2022-03-22

6.  Chrono-Aerobic Exercise Optimizes Metabolic State in DB/DB Mice through CLOCK-Mitophagy-Apoptosis.

Authors:  Zhe Zhang; Xi Li; Jun Zhang; Jing Du; Qiang Zhang; Zhe Ge; Shuzhe Ding
Journal:  Int J Mol Sci       Date:  2022-08-18       Impact factor: 6.208

7.  Impact of sodium glucose cotransporter-2 inhibitors on liver steatosis/fibrosis/inflammation and redox balance in non-alcoholic fatty liver disease.

Authors:  Francesco Bellanti; Aurelio Lo Buglio; Michał Dobrakowski; Aleksandra Kasperczyk; Sławomir Kasperczyk; Palok Aich; Shivaram P Singh; Gaetano Serviddio; Gianluigi Vendemiale
Journal:  World J Gastroenterol       Date:  2022-07-14       Impact factor: 5.374

8.  Dezocine regulates the malignant potential and aerobic glycolysis of liver cancer targeting Akt1/GSK-3β pathway.

Authors:  Zi-Wen Zhong; Wen-Chang Zhou; Xing-Feng Sun; Qi-Chao Wu; Wan-Kun Chen; Chang-Hong Miao
Journal:  Ann Transl Med       Date:  2020-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.